Reportedly, in addition to the big 4 driver mutations of KRAS, TP53, CDKN2A, and SMAD4, the mutations in critical genes involved in the development and maintenance of pancreatic tissues are associated with pancreatic cancer with variable penetrance [13]. The gene discussed is CDKN2A; the disease is familial pancreatic carcinoma.